You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Performance of anti-CD19 chimeric antigen receptor T cells in genetically defined classes of chronic lymphocytic leukemia

Article info

Article menu

Download PDFPDF

XML
Immune cell therapies and immune cell engineering
Original research
Performance of anti-CD19 chimeric antigen receptor T cells in genetically defined classes of chronic lymphocytic leukemia

Authors

  • Veronika Mancikova Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic Department of Internal Medicine-Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic PubMed articlesGoogle scholar articles
  • Helena Peschelova Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic PubMed articlesGoogle scholar articles
  • Veronika Kozlova Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic Department of Internal Medicine-Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic PubMed articlesGoogle scholar articles
  • Aneta Ledererova Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic Department of Internal Medicine-Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic PubMed articlesGoogle scholar articles
  • Adriana Ladungova Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic PubMed articlesGoogle scholar articles
  • Jan Verner Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic Department of Internal Medicine-Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic PubMed articlesGoogle scholar articles
  • Tomas Loja Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic PubMed articlesGoogle scholar articles
  • Frantisek Folber Department of Internal Medicine-Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic PubMed articlesGoogle scholar articles
  • Jiri Mayer Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic Department of Internal Medicine-Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic PubMed articlesGoogle scholar articles
  • Sarka Pospisilova Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic Department of Internal Medicine-Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic PubMed articlesGoogle scholar articles
  • Michal Smida Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic Department of Internal Medicine-Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic PubMed articlesGoogle scholar articles

Citation

Mancikova V, Peschelova H, Kozlova V, et al
Performance of anti-CD19 chimeric antigen receptor T cells in genetically defined classes of chronic lymphocytic leukemia
Journal for ImmunoTherapy of Cancer 2020;8:e000471. doi: 10.1136/jitc-2019-000471
Online issue publication 
January 11, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.